Gabon research centre says antimalarial drug within reach

April 25, 2012

A scientist at the Albert Schweitzer Hospital's medical research unit said Wednesday that trials of a new antimalarial drug were encouraging and paved the way for licensing.

"These preliminary results are relatively encouraging and lead us to believe... that we could have something licensed," Dr Jose Fernandez said in Libreville at an event marking World Malaria Day.

He said the drug had been in the final of three clinical trial phases for the past two years at the research centre in Lambarene, the Gabon jungle town where winner Schweitzer founded the hospital 99 years ago.

The RTS,S/AS01E vaccine is manufactured by British pharmaceutical giant GlaxoSmithKline and the research -- which is led by the University of Tubingen -- is being financed by the .

Fernandez said the vaccine had achieved 56 percent protection from malaria and 46 percent against severe malaria.

While global campaigning and wide distributions of have helped curb malaria, it is still regarded as the worst parasitic disease in the world.

The says 655,000 people died of malaria in 2010, making the mosquito-borne disease the world's fifth biggest killer in low-income countries.

Speaking at the same event in Libreville, Gabonese Health Minister Leon Nzouba described malaria as his country's top public health problem.

Schweitzer, who was born a German and later became French, was also a respected philosopher, organist, musicologist and theologian. He died in the hospital he founded in 1965 at the age of 90.

Explore further: WHO hails big gains in anti-malaria fight

Related Stories

WHO hails big gains in anti-malaria fight

April 24, 2012

The World Health Organisation heralded major gains Tuesday in the fight against malaria, one of the developing world's biggest killers, but warned universal access to treatment remains elusive.

Recommended for you

Researchers discover rare flu-thwarting mutation

September 29, 2016

A rare and improbable mutation in a protein encoded by an influenza virus renders the virus defenseless against the body's immune system. This University of Rochester Medical Center discovery could provide a new strategy ...

Utah man may have contracted Zika from dying father's tears

September 29, 2016

A Utah man who mysteriously contracted Zika from his infected father may have got it by touching his dad's tears or sweat with his bare hands, according to new research unveiled Wednesday that found the unusual transmission ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.